<DOC>
	<DOCNO>NCT01400334</DOCNO>
	<brief_summary>The hypothesis PAREPET hibernate myocardium ( viable myocardium reduce rest flow ) and/or viable denervated myocardium predict risk sudden death subject ischemic cardiomyopathy .</brief_summary>
	<brief_title>Prediction ARrhythmic Events With Positron Emission Tomography</brief_title>
	<detailed_description>Currently available electrophysiological approach limited ability identify majority patient CAD LV dysfunction succumb sudden cardiac death ( SCD ) . Half patient develop SCD inducible electrophysiological test underscore need new way identify substrate lead arrhythmic death . Viable chronically dysfunctional reduce rest flow , hibernate myocardium , amenable revascularization appear major risk factor subsequent cardiac death present 60 % patient ischemic cardiomyopathy . Cause specific mortality data limit appear arrhythmic rather fatal myocardial infarction progressive heart failure . Revascularization improve survival patient hibernate myocardium manage medically due prohibitive procedural risk technical limitation . Basic study swine hibernate myocardium demonstrate SCD arise VT/VF absence myocardial scar heart failure . The central hypothesis proposal presence hibernate myocardium oppose scar identifies large subset patient ischemic cardiomyopathy high risk SCD . We hypothesize risk relate inhomogeneity sympathetic innervation arise chronic repetitive ischemia . PAREPET prospective observational study enroll patient coronary disease , Class I-III heart failure ejection fraction ≤35 % . Using positron emission tomography ( PET ) , frequency amount hibernate myocardium quantify patient candidate coronary revascularization . Three Specific Aims propose . Aim 1 determine whether image mismatch viability ( preserve 18F-2-deoxyglucose ) reduce rest flow ( 13NH3 ) predict increase risk SCD ( ICD discharge VT/VF surrogate end-point ) hibernate myocardium . Aim 2 image norepinephrine uptake use 11C-hydroxyephedrine determine whether inhomogeneity myocardial sympathetic innervation predict SCD risk well viability test . Aim 3 identify whether substrate identify PET stable abort SCD event evaluate temporal change function , viability sympathetic innervation patient ICD . Our long-term objective develop well approach identify patient CAD likely benefit primary prevention SCD placement ICD .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>LV EF ≤35 % ( nuclear imaging , cardiac catheterization echocardiography ) Coronary artery disease document cardiac catheterization , history definite myocardial infarction , reversible ischemia nuclear image New York State Heart Association functional Class IIII heart failure Not candidate surgical percutaneous coronary revascularization time enrollment History resuscitate sudden cardiac death , sustain ventricular tachycardia , appropriate implantable cardiac defibrillator ( ICD ) discharge , unexplained syncope Myocardial infarction within 30 day Coronary artery bypass graft within 1 year Percutaneous intervention within 3 month Claustrophobia physical limitation would preclude PET scan Pregnancy Tricyclic antidepressant drug therapy Comorbidities would expect result noncardiac death within 2 year Inability provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Ischemic Cardiomyopathy</keyword>
	<keyword>Sudden Cardiac Death</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Hibernating Myocardium</keyword>
	<keyword>Denervated Myocardium</keyword>
</DOC>